Literature DB >> 6259649

Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.

C I Johnston, B Clappison, B P McGrath, P G Matthews, J A Millar, W P Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6259649

Source DB:  PubMed          Journal:  Prog Biochem Pharmacol        ISSN： 0079-6085


× No keyword cloud information.
  3 in total

1.  Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Authors:  J A Millar; F H Derkx; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

2.  Urinary kallikrein excretion during inhibition of endogenous angiotensin II in the pig.

Authors:  B R Binder; M Maier; H Rana; M Starlinger; Z Zhegu
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

Review 3.  Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.

Authors:  R J Cody
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.